Neuroscienze e Neurologia Sperimentale

Laboratori 2024/2025 - Neuroscienze e Neurologia Sperimentale

Di seguito è possibile visionare l’elenco dei Supervisori (e i link ai rispettivi CV) e i progetti presentati per l' a.a. 2024/2025 all'interno del curriculum in Neuroscienze e Neurologia Sperimentale.

Nell'elenco sono riportate le borse a progetto e a seguire i progetti liberi tra cui i candidati, risultati idonei alla seconda fase di valutazione, dovranno scegliere i progetti di preferenza così come indicato nel bando.

4 BORSE A PROGETTO:

Borsa a Progetto NEN1: MENEGON ANDREA

Sede: CIS/Drug Screening Technologies and Alembic R&D – IRCCS Ospedale San Raffaele

Finanziata dall’Unione Europea – NextGeneration EU - ai sensi del DM 630/2024

NEN1: Acid Sensing Ion Channel isoform 3, role in glioblastoma (GBM) and as drug target for GBM treatment

Borsa a Progetto NEN2: DE GREGORIO DANILO

Sede: Neuropsychopharmacology Unit– IRCCS Ospedale San Raffaele

NEN2: Targeting the 5-HT2A receptor for treating alcohol use disorder (AUD)

Borsa a Progetto NEN3: ROCCA MARIA ASSUNTA

Sede: Neuroimaging of CNS White Matter Unit, INSPE, Division of Neuroscience – IRCCS Ospedale San Raffaele

Finanziata dall’Unione Europea – NextGeneration EU - ai sensi del DM 630/2024

NEN3: Application of structural and functional MRI techniques to characterize the substrates of motor impairment and to investigate the mechanisms of different rehabilitative strategies in multiple sclerosis patients

Borsa a Progetto NEN4:  ALBANO LUIGI

Sede: Neurosurgery and Stereotactic Radiosurgery– IRCCS Ospedale San Raffaele

NEN4: Evaluation of spinal cord stimulation assisted by motor rehabilitation training for restoring motor function after spinal cord injury

BONANOMI DARIO

Sede: Molecular Neurobiology

Probing and targeting dysfunctional cell phenotypes in motor neuron disease

CIONI JEAN-MICHEL

Sede: RNA Biology of the Neuron

Unravelling the pathogenic processes behind Charcot-Marie-Tooth Type 2B disease.

CODAZZI FRANCA

Sede: Neuropathophysiology

Monitoring the contribution of upper motor neurons in ALS progression and propagation

COLASANTE GAIA

Sede: Stem cells and neurogenesis

Investigating the role of Scn1a in non-neuronal cell types in the brain

COLNAGHI LUCA

Sede: Protein Signalling in Brain Physiology and Pathology

Project1: Transcriptomic profiling of subjects with major depressive disorder as a new clinical tool Project2: New insights into NEDAMSS, an incurable regressive neurodevelopmental syndrome

D'ADAMO PATRIZIA

Sede: Neuroimmunology

RAB39B gene therapy and AMPAR modulation in a pre-clinical mouse model for Intellectual Disability

D'ANTONIO MAURIZIO

Unit: Biology of Myelin

Dissecting the molecular mechanisms of TDP43 cell specific toxicity in in vivo models

DE GREGORIO DANILO

Sede: Neuropsychopharmacology

The additive effect of ketamine in combination with electroconvulsive stimulation (ECS) in major depressive disorder

ESPOSITO FEDERICA

Sede: Laboratory of human genetics of neurological disorders

Evaluation of changes induced by Ocrelizumab on the T and Blymphocyte repertoire in Relapsing-Remitting multiple sclerosis patients

FARINA CINTHIA

Sede: Immunobiology of neurological disorders

Blood Transcriptomics for multiple sclerosis phenotyping

FILIPPI  MASSIMO

Sede: Neurology

Defining a multimodal machine-learning algorithm to predict disability outcomes in Frontotemporal Lobar Degeneration

GALLI ROSSELLA

Sede: Neural stem cell biology

Deconstructing the involvement of abnormally protracted corticogenesis in the etiology of cortical defects in a postnatal mouse model of Tuberous Sclerosis Complex

MALTECCA FRANCESCA

Unit: Mitochondrial dysfunctions in neurodegeneration

Developing novel therapeutic approaches for neurogenerative diseases caused by AFG3L2 mutations

MARTINO GIANVITO

Sede: Neuroimmunology

Discovery of gene regulation programs in multiple sclerosis

PANINA PAOLA

Unit: Neuroimmunology

Unveiling the role of short-chain fatty acids in neural homeostasis

POLETTI SARA

Unit: Psychiatry and Clinical Psychobiology

Profiling vulnerability and resilience for mental illness following viral infections

ROCCA MARIA ASSUNTA

Sede: Neuroimaging of CNS White Matter Unit, INSPE, Division of Neuroscience

Identifying Distinct Diagnostic and Prognostic Phenotypes in rare central nervous system disimmune disorders

SASSONE JENNY

Unit: Neuropsychopharmacology

Investigating the role od necroptosis in the axonal degeneration associated with parkinson's disease

SESSA ALESSANDRO

Sede: Neuroepigenetics

Exploring the epigenetic rewiring associated to RLF mutations as a driver of intellectual disability

SIMONATO MICHELE

Sede: Gene therapy of neurodegenerative diseases

A combinatorial gene therapy for focal epilepsy based on coordinated expression of multiple GABA-A receptor subunits

TAVEGGIA CARLA

Sede: Axo-gliali interaction

Molecular Mechanisms regulating perineural invasion in pancreatic adenocarcinoma